Axogen Company Leadership

AXGN Stock  USD 12.47  0.07  0.56%   
Axogen's insiders are aggressively selling. The analysis of insiders' sentiment of trading Axogen Inc stock suggests that virtually all insiders are panicking at this time. Axogen employs about 426 people. The company is managed by 17 executives with a total tenure of roughly 42 years, averaging almost 2.0 years of service per executive, having 25.06 employees per reported executive.
Karen Zaderej  CEO
CEO and President and Director
Angelo Scopelianos  President
Vice President - Research & Development

Axogen's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-03-21Michael Patrick DonovanDisposed 6033 @ 7.68View
2024-03-07Michael Patrick DonovanDisposed 36310 @ 8.81View
2023-12-11Peter J MarianiDisposed 12500 @ 7.5View
Monitoring Axogen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Axogen's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Axogen's future performance. Based on our forecasts, it is anticipated that Axogen will maintain a workforce of about 430 employees by December 2024.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Axogen Management Team Effectiveness

The company has return on total asset (ROA) of (0.0275) % which means that it has lost $0.0275 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1451) %, meaning that it created substantial loss on money invested by shareholders. Axogen's management efficiency ratios could be used to measure how well Axogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 15th of November 2024, Return On Tangible Assets is likely to drop to -0.12. In addition to that, Return On Capital Employed is likely to grow to -0.12. At this time, Axogen's Debt To Assets are very stable compared to the past year. As of the 15th of November 2024, Asset Turnover is likely to grow to 0.95, though Non Currrent Assets Other are likely to grow to (83.2 M).
As of the 15th of November 2024, Common Stock Shares Outstanding is likely to grow to about 45 M, while Net Loss is likely to drop (27.4 M).

Axogen Workforce Comparison

Axogen Inc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 26,825. Axogen claims roughly 426 in number of employees contributing just under 2% to equities under Health Care industry.

Axogen Profit Margins

The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.01) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.01.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.460.8042
Way Down
Slightly volatile

Axogen Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Axogen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
1.4286
10
7
 538,703 
 83,328 
2024-06-01
17.0
17
1
 243,112 
 11,904 
2024-03-01
0.6071
17
28
 737,278 
 359,560 
2023-12-01
0.125
1
8
 65,476 
 20,836 
2023-06-01
0.7273
8
11
 67,504 
 91,952 
2023-03-01
1.0811
40
37
 1,159,669 
 347,782 
2022-12-01
1.2857
18
14
 134,031 
 124,494 
2022-09-01
0.7143
10
14
 184,452 
 256,508 
2022-06-01
3.2857
23
7
 190,580 
 34,455 
2022-03-01
1.3103
38
29
 1,574,765 
 121,653 
2021-12-01
0.5172
15
29
 82,250 
 92,812 
2021-09-01
0.7647
13
17
 202,027 
 187,177 
2021-06-01
1.6
32
20
 420,531 
 368,502 
2021-03-01
1.8182
40
22
 655,415 
 149,496 
2020-12-01
0.6667
20
30
 134,812 
 238,939 
2020-09-01
2.6667
8
3
 74,502 
 30,546 
2020-06-01
9.6667
29
3
 462,666 
 140,000 
2020-03-01
2.3529
40
17
 621,338 
 41,445 
2019-12-01
0.8889
8
9
 21,050 
 28,853 
2019-06-01
1.0
4
4
 70,922 
 126,008 
2019-03-01
1.5
9
6
 86,774 
 6,914 
2018-12-01
2.3636
26
11
 523,174 
 254,917 
2018-09-01
1.1429
8
7
 300,544 
 288,177 
2018-06-01
1.75
7
4
 50,900 
 37,682 
2018-03-01
0.2692
7
26
 140,650 
 464,357 
2017-12-01
1.4737
28
19
 391,596 
 2,600,928 
2017-09-01
0.5556
5
9
 175,150 
 80,618 
2017-06-01
3.5
7
2
 95,000 
 20,000 
2016-09-01
0.4286
3
7
 32,500 
 534,807 
2015-12-01
13.5
27
2
 752,250 
 17,263 
2015-09-01
0.7143
5
7
 229,000 
 424,659 
2015-06-01
8.0
8
1
 14,825 
 144,385 
2014-12-01
8.5
17
2
 318,500 
 50,000 
2014-06-01
9.5
19
2
 276,184 
 17,007 
2013-12-01
1.0
1
1
 290.00 
 290.00 
2013-03-01
2.6667
8
3
 138,296 
 6,796 
2012-06-01
1.0
2
2
 8,733 
 8,733 
2012-03-01
1.0
1
1
 1,500 
 15,019 
2011-12-01
8.4
42
5
 920,272 
 90,531 
2011-09-01
0.1111
1
9
 20,000 
 11,305 
2011-03-01
0.3333
2
6
 40,000 
 142,409 
2010-06-01
0.1111
1
9
 125,000 
 498,133 
2008-09-01
3.0
3
1
 98,000 
 3,727 
2004-03-01
2.0
2
1
 75,000 
 30,000 
2002-09-01
1.0
8
8
 213,000 
 213,000 

Axogen Notable Stakeholders

An Axogen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Axogen often face trade-offs trying to please all of them. Axogen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Axogen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Karen ZaderejCEO and President and DirectorProfile
Angelo ScopelianosVice President - Research & DevelopmentProfile
Erick DeVinneyVice President of Clinical and Translational SciencesProfile
Peter MarianiEx CFOProfile
Marc BeganGeneral VPProfile
Gregory DavaultVP MarketingProfile
Maria MartinezChief Human Resource OfficerProfile
CFA CPAChief OfficerProfile
Isabelle BilletChief Strategy and Business Development OfficerProfile
Jens KempChief OfficerProfile
Todd PuckettVice OperationsProfile
Bradley JDG OfficerProfile
Ed JoyceDirector RelationsProfile
Michael DonovanVice OperationsProfile
Doris QuackenbushVice SalesProfile
Ivica MDChief OfficerProfile
Harold TamayoVice RelationsProfile

About Axogen Management Performance

The success or failure of an entity such as Axogen Inc often depends on how effective the management is. Axogen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Axogen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Axogen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.11)(0.12)
Return On Capital Employed(0.13)(0.12)
Return On Assets(0.11)(0.12)
Return On Equity(0.23)(0.24)

Axogen Workforce Analysis

Traditionally, organizations such as Axogen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Axogen within its industry.

Axogen Manpower Efficiency

Return on Axogen Manpower

Revenue Per Employee373.3K
Revenue Per Executive9.4M
Net Loss Per Employee51K
Net Loss Per Executive1.3M
Working Capital Per Employee135.2K
Working Capital Per Executive3.4M
When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.33)
Revenue Per Share
4.16
Quarterly Revenue Growth
0.179
Return On Assets
(0.03)
Return On Equity
(0.15)
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.